financetom
Business
financetom
/
Business
/
Alaska Air Group Sees Q3 EPS At High End of Guidance Range Following Hawaiian Acquisition
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Alaska Air Group Sees Q3 EPS At High End of Guidance Range Following Hawaiian Acquisition
Oct 21, 2024 9:43 PM

02:08 PM EDT, 10/21/2024 (MT Newswires) -- Alaska Air Group ( ALK ) said Monday it expects Q3 earnings per share to be at the higher end of its guidance range, as the results will include 13 days of Hawaiian Holdings' performance since the September 18 acquisition.

The company also anticipates to post an adjusted Q3 pre-tax margin that is "the industry's best," driven by "positive" revenue and cost performance in Q3.

Alaska Air Group ( ALK ) shares were up 1.6% in recent trading.

Price: 45.65, Change: +0.71, Percent Change: +1.58

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CeriBell seeks up to $578 mln valuation in upsized US IPO
CeriBell seeks up to $578 mln valuation in upsized US IPO
Oct 10, 2024
Oct 9 (Reuters) - CeriBell said on Wednesday it was targeting a valuation of as much as $578.3 million in its upsized initial public offering in the United States, indicating strong investor demand for the medical device maker. The company is now aiming to raise as much as $180.3 million by offering about 10.6 million shares at $16 to $17...
BRIEF-Ceribell Inc Expects IPO Price To Be Between $16.00 And $17.00 Per Share
BRIEF-Ceribell Inc Expects IPO Price To Be Between $16.00 And $17.00 Per Share
Oct 10, 2024
Oct 9 (Reuters) - * CERIBELL INC SAYS NOW EXPECTS IPO PRICE TO BE BETWEEN $16.00 AND $17.00 PER SHARE - SEC FILING * CERIBELL INC - NOW SEES IPO OF UP TO 10.6 MILLION SHARES OF COMMON STOCK * CERIBELL INC SAYS IT HAD PREVIOUSLY EXPECTED IPO OF UP TO 6.7 MILLION COMMON SHARES TO BE PRICED BETWEEN $14...
Viatris Says EFFEXOR Met Primary Endpoint of Reducing Anxiety Symptoms in Phase 3 Trial
Viatris Says EFFEXOR Met Primary Endpoint of Reducing Anxiety Symptoms in Phase 3 Trial
Oct 10, 2024
07:58 AM EDT, 10/09/2024 (MT Newswires) -- Viatris ( VTRS ) said Wednesday its phase 3 trial in Japan evaluating EFFEXOR for generalized anxiety disorder met its primary objective, showing superiority over placebo in reducing anxiety symptoms at eight weeks. The trial, which assessed 804 patients, met primary and all secondary efficacy endpoints, Viatris ( VTRS ) said. EFFEXOR was...
Well Health Announces
Well Health Announces "Positive Findings" from OntarioMD AI Scribe Evaluation Study
Oct 10, 2024
07:30 AM EDT, 10/09/2024 (MT Newswires) -- WELL Health Technologies ( WHTCF ) on Wednesday said the final report from the AI Scribe Evaluation Study, conducted by OntarioMD, a subsidiary of the Ontario Medical Association, has been published. The study involved testing several AI scribes, including WELL's AI Voice (WAIV) solution, with 152 primary care providers across the province. It...
Copyright 2023-2026 - www.financetom.com All Rights Reserved